FR2070105B1 - - Google Patents

Info

Publication number
FR2070105B1
FR2070105B1 FR7035499A FR7035499A FR2070105B1 FR 2070105 B1 FR2070105 B1 FR 2070105B1 FR 7035499 A FR7035499 A FR 7035499A FR 7035499 A FR7035499 A FR 7035499A FR 2070105 B1 FR2070105 B1 FR 2070105B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7035499A
Other languages
French (fr)
Other versions
FR2070105A1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratorios Hosbon SA
Original Assignee
Laboratorios Hosbon SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Hosbon SA filed Critical Laboratorios Hosbon SA
Publication of FR2070105A1 publication Critical patent/FR2070105A1/en
Application granted granted Critical
Publication of FR2070105B1 publication Critical patent/FR2070105B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7035499A 1969-10-02 1970-10-01 Oral compns contg lipophilic substances Granted FR2070105A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES37247669 1969-10-02

Publications (2)

Publication Number Publication Date
FR2070105A1 FR2070105A1 (en) 1971-09-10
FR2070105B1 true FR2070105B1 (en) 1974-05-24

Family

ID=8454084

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7035499A Granted FR2070105A1 (en) 1969-10-02 1970-10-01 Oral compns contg lipophilic substances

Country Status (3)

Country Link
BE (1) BE756992A (en)
DE (1) DE2044904A1 (en)
FR (1) FR2070105A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5039699A (en) * 1989-03-27 1991-08-13 Lederle (Japan), Ltd. Anti-peptic ulcer agent

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6603111A (en) * 1956-11-24 1966-09-20
FR5080M (en) * 1965-12-03 1967-05-16

Also Published As

Publication number Publication date
BE756992A (en) 1971-03-16
DE2044904A1 (en) 1971-04-22
FR2070105A1 (en) 1971-09-10

Similar Documents

Publication Publication Date Title
AU2270770A (en)
AU465452B2 (en)
AU4221168A (en)
AU450150B2 (en)
CS153092B2 (en)
AU442375B2 (en)
AU2355770A (en)
FR2070105B1 (en)
AU427401B2 (en)
AU442322B2 (en)
AU442463B2 (en)
AU470661B1 (en)
AU442554B2 (en)
AU442538B2 (en)
AU442535B2 (en)
AU442380B2 (en)
AU442357B2 (en)
AU442285B2 (en)
AT308690B (en)
AU438128B2 (en)
AU428131B2 (en)
AU428074B2 (en)
AU425297B2 (en)
AU417208B2 (en)
AU410358B2 (en)

Legal Events

Date Code Title Description
ST Notification of lapse